• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 10-Q filed by Syntec Optics Holdings Inc.

    10/3/25 8:15:17 PM ET
    $OPTX
    Electronic Components
    Technology
    Get the next $OPTX alert in real time by email
    false Q1 --12-31 0001866816 0001866816 2025-01-01 2025-03-31 0001866816 OPTX:CommonStockParValue0.0001PerShareMember 2025-01-01 2025-03-31 0001866816 OPTX:RedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember 2025-01-01 2025-03-31 0001866816 2025-10-03 0001866816 2025-03-31 0001866816 2024-12-31 0001866816 us-gaap:CommonClassAMember 2025-03-31 0001866816 us-gaap:CommonClassAMember 2024-12-31 0001866816 2024-01-01 2024-03-31 0001866816 us-gaap:CommonStockMember 2024-12-31 0001866816 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001866816 us-gaap:RetainedEarningsMember 2024-12-31 0001866816 us-gaap:CommonStockMember 2023-12-31 0001866816 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001866816 us-gaap:RetainedEarningsMember 2023-12-31 0001866816 2023-12-31 0001866816 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001866816 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001866816 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001866816 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001866816 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001866816 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001866816 us-gaap:CommonStockMember 2025-03-31 0001866816 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001866816 us-gaap:RetainedEarningsMember 2025-03-31 0001866816 us-gaap:CommonStockMember 2024-03-31 0001866816 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001866816 us-gaap:RetainedEarningsMember 2024-03-31 0001866816 2024-03-31 0001866816 OPTX:ProductsMember 2025-01-01 2025-03-31 0001866816 OPTX:ProductsMember 2024-01-01 2024-03-31 0001866816 OPTX:CustomToolingMember 2025-01-01 2025-03-31 0001866816 OPTX:CustomToolingMember 2024-01-01 2024-03-31 0001866816 OPTX:NonRecurringEngineeringMember 2025-01-01 2025-03-31 0001866816 OPTX:NonRecurringEngineeringMember 2024-01-01 2024-03-31 0001866816 OPTX:CommunicationMember 2025-01-01 2025-03-31 0001866816 OPTX:CommunicationMember 2024-01-01 2024-03-31 0001866816 OPTX:ConsumerMember 2025-01-01 2025-03-31 0001866816 OPTX:ConsumerMember 2024-01-01 2024-03-31 0001866816 OPTX:DefenseMember 2025-01-01 2025-03-31 0001866816 OPTX:DefenseMember 2024-01-01 2024-03-31 0001866816 OPTX:MedicalMember 2025-01-01 2025-03-31 0001866816 OPTX:MedicalMember 2024-01-01 2024-03-31 0001866816 us-gaap:MachineryAndEquipmentMember 2025-03-31 0001866816 us-gaap:MachineryAndEquipmentMember 2024-12-31 0001866816 us-gaap:LandBuildingsAndImprovementsMember 2025-03-31 0001866816 us-gaap:LandBuildingsAndImprovementsMember 2024-12-31 0001866816 us-gaap:LandMember 2025-03-31 0001866816 us-gaap:LandMember 2024-12-31 0001866816 us-gaap:OfficeEquipmentMember 2025-03-31 0001866816 us-gaap:OfficeEquipmentMember 2024-12-31 0001866816 OPTX:ToolingMember 2025-03-31 0001866816 OPTX:ToolingMember 2024-12-31 0001866816 us-gaap:VehiclesMember 2025-03-31 0001866816 us-gaap:VehiclesMember 2024-12-31 0001866816 OPTX:MAndTBankTermNotePayableMember OPTX:NotesPayableMember 2025-03-31 0001866816 OPTX:MAndTBankTermNotePayableMember OPTX:NotesPayableMember 2024-12-31 0001866816 OPTX:MAndTBankTermNotePayableMember OPTX:NotesPayable1Member 2025-03-31 0001866816 OPTX:MAndTBankTermNotePayableMember OPTX:NotesPayable1Member 2024-12-31 0001866816 OPTX:MAndTBankTermNotePayableMember OPTX:NotesPayable2Member 2025-03-31 0001866816 OPTX:MAndTBankTermNotePayableMember OPTX:NotesPayable2Member 2024-12-31 0001866816 OPTX:MAndTBankTermNotePayableMember OPTX:NotesPayable3Member 2025-03-31 0001866816 OPTX:MAndTBankTermNotePayableMember OPTX:NotesPayable3Member 2024-12-31 0001866816 OPTX:USSmallBusinessAdministrationTermNotePayableMember OPTX:NotesPayable4Member 2025-03-31 0001866816 OPTX:USSmallBusinessAdministrationTermNotePayableMember OPTX:NotesPayable4Member 2024-12-31 0001866816 OPTX:MAndTBankTermNotePayableMember OPTX:NotesPayable1Member 2025-01-01 2025-03-31 0001866816 OPTX:MAndTBankTermNotePayableMember OPTX:NotesPayable2Member 2025-01-01 2025-03-31 0001866816 OPTX:MAndTBankTermNotePayableMember OPTX:NotesPayable3Member 2025-01-01 2025-03-31 0001866816 OPTX:MAndTBankTermNotePayableMember OPTX:NotesPayable4Member 2025-03-31 0001866816 OPTX:MAndTBankTermNotePayableMember OPTX:NotesPayable4Member 2025-01-01 2025-03-31 0001866816 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember OPTX:ThreeCustomersMember 2025-01-01 2025-03-31 0001866816 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember OPTX:ThreeCustomersMember 2025-03-31 0001866816 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember OPTX:ThreeCustomersMember 2024-01-01 2024-03-31 0001866816 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember OPTX:ThreeCustomersMember 2024-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares OPTX:Integer xbrli:pure

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 10-Q

     

    (MARK ONE)

    ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

     

    For the quarter ended March 31, 2025

     

    OR

     

    ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

     

    For the transition period from to

     

    Commission file number: 001-41034

     

    SYNTEC OPTICS HOLDINGS, INC.

    (Exact Name of Registrant as Specified in Its Charter)

     

    Delaware 87-0816957

    (State or other jurisdiction of

    incorporation or organization)

    (I.R.S. Employer

    Identification No.)

     

    515 Lee Rd.

    Rochester, NY 14606

    (Address of principal executive offices and zip code)

     

    (585) 464-9336

    (Registrant’s telephone number including area code)

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class Trading Symbol(s) Name of each exchange on which registered
    Common stock, par value $0.0001 per share OPTX The Nasdaq Capital Market
    Redeemable warrants, exercisable for shares of common stock at an exercise price of $11.50 per share OPTXW The Nasdaq Capital Market

     

    Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

     

    Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer ☐ Accelerated filer ☐
    Non-accelerated filer ☒ Smaller reporting company ☒
    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

    Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

     

    As of October 3, 2025, there were 36,920,226 shares of Class A common stock, par value $0.0001 per share, issued and outstanding.

     

     

     

     

     

     

    SYNTEC OPTICS HOLDINGS, INC.

    FORM 10-Q FOR THE QUARTER ENDED MARCH 31, 2025

    TABLE OF CONTENTS

     

    Page
    Part I. FINANCIAL INFORMATION 1
    Item 1. Interim Unaudited Condensed Consolidated Financial Statements 1
    Condensed Consolidated Balance Sheets as of March 31, 2025 (Unaudited) and December 31, 2024 1
    Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2025 and 2024 (Unaudited) 2
    Condensed Consolidated Statements of Stockholders’ Equity for the Three Months Ended March 31, 2025 and 2024 (Unaudited) 3
    Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2025 and 2024 (Unaudited) 4
    Notes to Condensed Consolidated Financial Statements (Unaudited) 5
    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 12
    Item 3. Quantitative and Qualitative Disclosures Regarding Market Risk 17
    Item 4. Controls and Procedures 18
    Part II. OTHER INFORMATION 19
    Item 1. Legal Proceedings 19
    Item 1A. Risk Factors 19
    Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 19
    Item 3. Defaults Upon Senior Securities 19
    Item 4. Mine Safety Disclosures 19
    Item 5. Other Information 19
    Item 6. Exhibits 19
    SIGNATURES 20

     

     

     

     

    PART I - FINANCIAL INFORMATION

     

    Item 1. Interim Unaudited Condensed Consolidated Financial Statements

     

    SYNTEC OPTICS HOLDINGS, INC.

    UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

    MARCH 31, 2025 AND DECEMBER 31, 2024

     

       2025
    (unaudited)
       2024 
    ASSETS          
               
    Current Assets          
    Cash  $540,904   $598,787 
    Accounts Receivable, Net   6,322,759    5,739,205 
    Inventory   7,595,025    6,953,278 
    Income Tax Receivable   -    9,794 
    Prepaid Expenses and Other Assets   563,102    596,589 
               
    Total Current Assets   15,021,790    13,897,653 
               
    Property and Equipment, Net   11,004,158    11,668,859 
               
    Deferred Tax Asset   

    270,360

        

    439,942

     
               
    Total Assets  $26,296,308   $26,006,454 
               
    LIABILITIES AND STOCKHOLDERS’ EQUITY          
               
    Current Liabilities          
    Accounts Payable  $2,655,515   $2,706,392 
    Accrued Expenses   975,991    814,600 
    Deferred Revenue   32,213    36,512 
    Line of Credit   

    6,263,863

        

    6,263,863

     
    Current Maturities of Debt Obligations   473,956    467,742 
    Current Maturities of Finance Lease Obligations   365,274    284,002 
               
    Total Current Liabilities   10,766,812    10,573,111 
               
    Long-Term Liabilities          
    Long-Term Debt Obligations   2,496,737    2,614,812 
    Long-Term Finance Lease Obligations   1,675,012    1,784,449 
               
    Total Long-Term Liabilities   4,171,749    4,399,261 
               
    Total Liabilities   14,938,561    14,972,372 
               
    Commitments and Contingencies   -    - 
               
    Stockholder’s Equity          
    CL A Common Stock, Par value $.0001 per share; 121,000,000 authorized; 36,920,226 issued and outstanding as of March 31, 2025; 36,688,266 issued and outstanding as of December 31, 2024;   3,692    3,669 
    Common stock, value   3,692    3,669 
    Additional Paid-In Capital   2,377,181    2,377,204 
    Retained Earnings   8,976,874    8,653,209 
               
    Total Stockholder’s Equity   11,357,747    11,034,082 
               
    Total Liabilities and Stockholder’s Equity  $26,296,308   $26,006,454 

     

    The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

     

    1
     

     

    SYNTEC OPTICS HOLDINGS, INC.

    UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

    FOR THE THREE MONTHS ENDED MARCH 31, 2025 AND 2024

     

       2025   2024 
             
    Net Sales  $7,069,042   $6,255,908 
               
    Cost of Goods Sold   4,760,424    5,548,465 
               
    Gross Profit   2,308,618    707,443 
               
    General and Administrative Expenses   1,780,166    2,114,543 
               
    Income (Loss) from Operations   528,452    (1,407,100)
               
    Other Income (Expense)          
    Interest Expense, Including Amortization of Debt Issuance Costs   (200,896)   (159,867)
    Other Income   5,697    19,349 
               
    Total Other (Expense)   (195,199)   (140,518)
               
    Income (Loss) Before Provision (Benefit) for Income Taxes   333,253    (1,547,618)
               
    Provision (Benefit) for Income Taxes   9,588    (338,475)
               
    Net Income (Loss)  $323,665   $(1,209,143)
               
    Net Income (Loss) per Common Share          
    Basic and diluted  $0.01   $(0.03)
               
    Weighted Average Number of Common Shares Outstanding          
    Basic and diluted   36,920,226    36,688,266 

      

    The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

     

    2
     

     

    SYNTEC OPTICS HOLDINGS, INC.

    UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

    FOR THE THREE MONTHS ENDING MARCH 31, 2025

     

               Additional         
       Common Stock   Paid-In   Retained     
       Shares   Amount   Capital   Earnings   Total 
                         
    Balances, January 1, 2025   36,688,266   $3,669   $2,377,204   $8,653,209   11,034,082 
                              
    Net Income   -    -    -    323,665    323,665 
                              
    Stock-Based Compensation   231,960    23    (23)   -    - 
                              
    Balances, March 31, 2025   36,920,226   $3,692   $2,377,181   $8,976,874   $11,357,747 

     

    SYNTEC OPTICS HOLDINGS, INC.

    UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

    FOR THE THREE MONTHS ENDING MARCH 31, 2024

     

               Additional         
       Common Stock   Paid-In   Retained     
       Shares   Amount   Capital   Earnings   Total 
                         
    Balances, January 1, 2024   36,688,266   $3,669   $1,927,204   $11,132,869   13,063,742 
    Balances   36,688,266   $3,669   $1,927,204   $11,132,869   13,063,742 
                              
    Net Income   -    -    -    (1,209,143)   (1,209,143)
                              
    Balances, March 31, 2024   36,688,266   $3,669   $1,927,204   $9,923,726   $ 11,854,599 
    Balances   36,688,266   $3,669   $1,927,204   $9,923,726   $ 11,854,599 

     

    The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

     

    3
     

     

    SYNTEC OPTICS HOLDINGS, INC.

    UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    FOR THE THREE MONTHS ENDED MARCH 31, 2025 AND 2024

     

       2025   2024 
    Cash Flows From Operating Activities          
    Net Income (Loss)  $323,665   $(1,209,143)
    Adjustments to Reconcile (Loss) Income to Net Cash (Used In) Provided By Operating Activities:                
    Adjustments to Reconcile (Loss) Income to Net Cash (Used In) Provided By Operating Activities:          
    Depreciation and Amortization   710,804    695,826 
    Amortization of Debt Issuance Costs   2,416    1,973 
    Change in Allowance for Expected Credit Losses   (15,244)   (24,103)
    Change in Reserve for Obsolescence   50,345    208,287
    Deferred Income Taxes   -    (181,882)
               
    (Increase) Decrease in:         
    Accounts Receivable   (568,310)   1,729,951
    Inventory   (692,092)   (848,028)
    Decrease in Federal Income Tax Receivable   179,376    - 
    Prepaid Expenses and Other Assets   33,487    (37,679)
    Increase (Decrease) in:        - 
    Accounts Payables and Accrued Expenses   279,142    (522,630)
    Federal Income Tax Payable   -    (122,776)
    Deferred Revenue   (4,299)   20,363
               
    Net Cash Provided By (Used In) Operating Activities   299,290    (289,841)
               
    Cash Flows From Investing Activities          
    Purchases of Property and Equipment   (214,731)   (95,218)
               
    Net Cash Used in Investing Activities   (214,731)   (95,218)
               
    Cash Flows From Financing Activities          
    Borrowing on Debt Obligations   -    1,100,388 
    Repayments on Debt Obligations   (114,277)   (88,878)
    Repayments on Finance Lease Obligations   (28,165)   - 
               
    Net Cash (Used In) Provided By Financing Activities   (142,442)   1,011,510
               
    Net Decrease in Cash   (57,883)   626,451 
               
    Cash - Beginning   598,787    2,158,245 
               
    Cash - Ending  $540,904   $2,784,696 
               
    Supplemental Cash Flow Disclosures:          
               
    Cash Paid for Interest  $201,956   $157,895 
               
    Cash Paid for Taxes  $-   $85,098 
               
    Supplemental Disclosures of Non-Cash Investing Activities:          
               
    Changes in Assets Acquired and Included in Accounts Payable and Accrued Expenses  $168,628  $412,641 
    Issuance of restricted common stock for stock-based compensation  $23   $- 

     

    The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

     

    4
     

     

    SYNTEC OPTICS HOLDINGS, INC.

    NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

     

    Note 1 — Description of Organization and Business Operations

     

    Nature of Business

     

    Syntec Optics Holdings, Inc. (the “Company” or “Syntec Optics”) is a vertically integrated manufacturer of optics and photonics components and sub-systems – from opto-mechanicals to optical elements of various geometries, diamond turned optics – both prototype and production, and optical systems including optics assembly, electro-optics assembly, design, and coating. Sales are made to customers in the United States and Europe in defense, medical, and consumer end-markets.

     

    Note 2 — Summary of Significant Accounting Policies

     

    The Company has provided a discussion of significant accounting policies, estimates and judgements in its 2024 Annual Report. There have been no changes to the Company’s significant accounting policies since December 31, 2024.

     

    Basis of Presentation

     

    The accompanying interim unaudited condensed consolidated financial statements have been prepared by the Company in United States (“U.S.”) dollars and pursuant to the rules and regulations of the United States Securities and Exchange Commission (“SEC”), the instructions to Form 10-Q and the provisions of Regulation S-X pertaining to interim financial statements. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the U.S. have been condensed or omitted. The interim unaudited condensed consolidated financial statements and notes included in this report should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024. In the opinion of management, these interim unaudited condensed consolidated financial statements include all adjustments and accruals of a normal and recurring nature necessary to fairly state the results of the interim periods presented. The results for interim periods are not necessarily indicative of results to be expected for the full year or for any future periods.

     

    Note 3 Segment reporting

     

    The Company operates as one operating segment. The Company’s chief operating decision maker (“CODM”) is its Chief Executive Officer, who reviews the financial statements on a consolidated basis. The CODM uses the Company’s long-range plan to allocate resources. The CODM makes decisions on resource allocation, assessments of performance, and monitors budget versus actual results using consolidated loss from operations.

     

    Significant expenses within loss from operations, as well as within net loss, include general and administrative expenses, and other expenses which are each separately presented on the Company’s Consolidated Statements of Operations and Comprehensive Loss.

     

    5
     

     

    SYNTEC OPTICS HOLDINGS, INC.

    NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

     

    Note 4 — Disaggregated Revenues

     

    The following table disaggregates revenue by revenue recognition methodologies as outlined above for the three months ended March 31:

     

    Schedule of Disaggregated Revenues

       2025   2024 
       Three Months Ended March 31 
       2025   2024 
             
    Products  $6,920,222   $6,250,703 
    Custom Tooling   118,820    4,205 
    Non-Recurring Engineering   30,000    1,000 
               
    Total  $7,069,042   $6,255,908 

     

    Syntec Optics’ management periodically reviews its revenues by its consumer, communication, medical, and defense end-markets. The purpose of this analysis is to determine its end market mix and identify trends. The following table disaggregates revenue as outlined above for the three months ended March 31:

     

       2025   2024 
       Three Months Ended March 31 
       2025   2024 
             
    Communication  $1,861,378   $2,057,262 
    Consumer  1,163,289    1,237,985 
    Defense  1,558,502    1,193,315 
    Medical   2,485,873    1,767,346 
               
    Total  $7,069,042   $6,255,908 

     

    6
     

     

    SYNTEC OPTICS HOLDINGS, INC.

    NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

     

    Note 5 — Inventory

     

    Inventory consists of the following at March 31, 2025 and December 31, 2024:

     

    Schedule of Inventory

       2025   2024 
             
    Raw Materials  $632,930   $487,405 
    Work-in-Process   7,324,637    6,815,425 
    Finished Goods   190,708    153,353 
    Inventory gross   8,148,275    7,456,183 
    Less: Reserve for Obsolescence   553,250    502,905 
               
    Inventory  $7,595,025   $6,953,278 

     

    Note 6 — Property and Equipment

     

    Property and equipment consists of the following at March 31, 2025 and December 31, 2024:

     

    Schedule of Property and Equipment

       2025   2024 
             
    Machinery and Equipment  $34,470,732   $34,430,556 
    Building and Leasehold Improvements   5,483,616    5,483,616 
    Land   130,000    130,000 
    Office Furniture and Equipment   2,295,749    2,295,749 
    Tooling   169,308    163,381 
    Vehicles   24,059    24,059 
    Property and Equipment, Gross   42,573,464    42,527,361 
    Less: Accumulated Depreciation   31,569,306    30,858,502 
               
    Property and Equipment, Net  $11,004,158   $11,668,859 

     

    Depreciation expenses were approximately $710,804 and $695,826 for the three months ended March 31, 2025 and 2024, respectively.

     

    7
     

     

    SYNTEC OPTICS HOLDINGS, INC.

    NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

     

    Note 7 — Line of Credit

     

    The Company has a line of credit available in the amount of $8,000,000 with M&T Bank (the “Credit Agreement”). Borrowings may be made against the line of credit as Secured Overnight Financing Rate (“SOFR”) Loans. The weighted average rate on outstanding borrowings as of March 31, 2025 was 7.31%. As of March 31, 2025 and December 31, 2024, the Company had $6,263,863 outstanding under the line of credit facility.

     

    The Credit Agreement contains customary covenants and restrictions on the Company’s ability to engage in certain activities and financial covenants requiring the Company to maintain certain financial ratios. At March 31, 2025, the Company was in compliance with the minimum fixed charge coverage ratio, maximum total leverage ratio, and the minimum EBITDA requirement as defined in the Credit Agreement.

     

    Note 8 — Long-Term Debt

     

    Long-term debt consists of the following at March 31, 2025 and December 31, 2024:

     

    Schedule of Long Term Debt Maturities

       2025   2024 
             
    The Company entered into a Line of Credit agreement which has a maturity date of November 8, 2026. See details in note 7.  $

    6,263,863

       $

    6,263,863

     
    The Company entered into a $863,607 mortgage note payable, securitized by the Company’s real estate and cross-collateralized with all Company assets, with M&T Bank, requiring monthly installments of $7,389, including interest at a fixed rate of 6.13%. The note matures in February 2029. 

    $

    827,419  

    $

    836,815 
               
    The Company entered into a $236,781 term note payable with M&T Bank, requiring monthly principal installments of $3,385, plus interest at a fixed rate of 6.05%. The note matures in March 2029.   195,138    205,829 
               
    The Company entered into a $1,775,000 term note payable with M&T Bank, requiring monthly principal installments of $34,886 plus interest at a fixed rate of 6.59%. The note matures in November 2028.   1,355,256    1,436,662 
               
    The Company entered into a $1,064,000 term note payable with the U.S. Small Business Administration, requiring monthly installments of $6,652, including fees and interest at a fixed rate of 2.22%.  The note matures in June 2036. The note is secured by certain assets of the Company and a personal guaranty of the Company’s stockholder.   655,221    668,006 
               
    Total Long-Term Debt   3,033,034    3,147,312 
               
    Less: Unamortized Debt Issuance Costs   62,341    64,758 
               
    Long-Term Debt, Less Unamortized Debt Issuance Costs   2,970,693    3,082,554 
               
    Less: Current Maturities   473,956    467,742 
               
    Long-Term Debt  $2,496,737   $

    2,614,812

     

      

    At March 31, 2025, the future debt maturities are as follows:

     

    Schedule of Long Term Future Debt Maturities

          
    December 31, 2025 (remainder of year)  $353,808 
    2026   497,991 
    2027   529,310 
    2028   492,668 
    2029   117,261 
    Thereafter   1,041,996 
    Total  $3,033,034 

     

    8
     

     

    SYNTEC OPTICS HOLDINGS, INC.

    NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

     

    Note 9 — Retirement Plan

     

    The Company maintains a 401(k) retirement plan covering eligible employees of the Company and its affiliate. Under the plan, participants may defer a percentage of their annual compensation, with Syntec Optics matching 50% of employee contributions not to exceed 6% of annual compensation. Total contributions for the Company for the three months ended March 31, 2025 and 2024 amounted to $49,000 and $45,000, respectively.

     

    Note 10 — Income Taxes

     

    The income tax provision for interim periods is determined using an estimate of the annual effective tax rate, adjusted for discrete items, if any, that are taken into account in the relevant period. Each quarter, the estimate of the annual effective tax rate is updated, and if the estimated effective tax rate changes, a cumulative adjustment is made.

     

    The effective income tax rate was 20.28% and 21.9% for the three months ended March 31, 2025 and 2024, respectively.

     

    Note 11 — Leases

     

    During 2024, the Company entered into finance lease agreements for equipment utilized in its manufacturing facility.

     

    The components of operating and finance lease costs are as follows for the three months ended March 31:

     Schedule of Operating Lease and Finance Lease Costs

       2025   2024 
       Three Months ended March 31 
       2025   2024 
    Operating lease cost  $-   $- 
    Finance Lease Cost:          
    Amortization of assets  82,157    - 
    Interest on liabilities  41,764    - 
               
    Total lease cost  $123,921   $- 

     

    Supplemental cash flow information related to leases are as follows for the three months ended March 31:

     Schedule of Cash Flow Information Related To Leases

       2025   2024 
       Three Months ended March 31 
       2025   2024 
    Cash paid for amounts included in measurement of lease obligations:          
    Operating cash flows from operating leases  $-   $- 
    Operating cash flows from finance leases  41,764   - 
    Financing cash flows from finance leases  $28,165   $- 

     

    The following table summarizes weighted average remaining lease term and discount rates as of March 31, 2025, and December 31, 2024:

     Schedule of Weighted Average Remaining Lease Term

       2025   2024 
    Weighted average remaining lease term (years)          
    Operating leases   N/A     N/A  
    Finance leases   4.76    5.00 
    Weighted average discount rate          
    Operating leases   N/A     N/A  
    Finance leases   8.4%   8.4%

     

    9
     

     

    SYNTEC OPTICS HOLDINGS, INC.

    NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

     

    Future maturities of our lease liabilities are as follows as of March 31, 2025:

     Schedule of Future Maturities of Lease Liabilities

          
    2025 remainder of year  $385,142 
    2026   513,525 
    2027   513,525 
    2028   513,525 
    2029   513,525 
    Thereafter   0 
    Total Undiscounted Lease Obligations   2,439,242 
    Less: Imputed Interests   398,956 
          
    Present Value of Lease Obligations  $2,040,286 

     

    Note 12 — Warrants

     

    The following tables presents a roll-forward of the Company’s warrants from December 31, 2024 to March 31, 2025:

     Schedule of Warrant

       Common Stock Warrants 
         
    Warrants outstanding, December 31, 2024   14,107,989 
    Warrants exercised   - 
    Warrants outstanding, March 31, 2025   14,107,989 

      

    10
     

     

    SYNTEC OPTICS HOLDINGS, INC.

    NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

     

    Note 13 — Income (Loss) Per Share

     

    The following table sets forth the information needed to compute basic and diluted earnings (loss) per share for the three months ended March 31, 2025 and 2024:

     Schedule of Basic And Diluted (Loss) Earnings Per Share

       2025   2024 
       Three months ended March 31, 
       2025   2024 
    Basic and diluted net income (loss) per share          
    Numerator:          
    Net income (loss)  $323,665   $(1,209,143)
               
    Denominator          
    Weighted-average shares outstanding   36,920,226    36,688,266 
    Basic and diluted net income (loss) per share  $0.01   $(0.03)

     

    Note that there were no potentially dilutive shares that were excluded from the weighted-average share calculation as of March 31, 2025 and 2024.

     

    Note 14 — Significant Customers

     

    For the three months ended March 31, 2025, the Company generated 46% of revenues from three customers. These three customers are in different end-markets utilizing diverse manufacturing capabilities from the Company. The outstanding accounts receivable due from these customers were approximately $3.3 million as of March 31, 2025.

     

    For the three months ended March 31, 2024, the Company generated 53% of revenues from three customers. These three customers are in different end-markets utilizing diverse manufacturing capabilities from the Company. The outstanding accounts receivable due from these customers were approximately $3.1million as of March 31, 2024.

     

    11
     

     

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

     

    The information in this Management’s Discussion and Analysis should be read in conjunction with the accompanying unaudited condensed financial statements and notes.

     

    Cautionary Note Regarding Forward-Looking Statements

     

    This report includes forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the Private Securities Litigation Reform Act of 1995. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions are intended to identify forward-looking statements. All statements other than statements of historical facts contained in this report, including among others, our strategy, future operations, future financial position, future revenue, projected costs, prospects, plans, objectives of management and expected market growth are forward-looking statements. Our actual results and financial condition may differ materially from those express or implied in such forward-looking statements. Therefore, you should not rely on any of these forward-looking statements.

     

    For a further list and description of various risks, relevant factors and uncertainties that could cause future results or events to differ materially from those expressed or implied in our forward-looking statements, see the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections in this report, our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and our other filings with the Securities and Exchange Commission (the “SEC”). All forward-looking statements in this report are made only as of the date hereof or as indicated and represent our views as of the date of this report. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update or revise any forward-looking statements, whether as the result of new information, future events or otherwise, except as required by law.

     

    Overview

     

    Syntec Optics is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making our own tools, molding, and nanomachining allows close interaction and recut ability, enabling special techniques to hold tolerances up to sub-micron level. Syntec has assembled a world class design for manufacturability team to augment its production team with deep expertise to fully leverage our vertical integration from component making to optics and electronics assembly. Syntec Optics has steadily developed variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin films deposition coatings, glass molding, polymer molding, tool-making, mechanicals manufacturing, and nanomachining.

     

    Syntec became a leader in the industry by pioneering polymer-based optics and then subsequently adding glass optics and optics made from other materials including crystals and metals. Polymer-based optics provide numerous advantages compared to incumbent glass-based optics. Polymer-based optics are smaller, lower weight, lower cost, and offer very high-performance optical solutions. For all these reasons, Syntec is able to deliver products to our clients that are lighter, smaller, and suitable for cutting edge technology products, including the newly evolving silicon photonics industry.

     

    Our designs and assembly processes are developed in-house in the United States. In 2016, Syntec Optics expanded its manufacturing facility to nearly 90,000 square-feet, allowing us to increase our production capacity and offer additional advanced manufacturing processes under one roof which provide us the ability to increase sales to existing customers and increase penetration of our end-markets. Our facility provides a streamlined, partially autonomous production process for our current customers, which comprises optical assembly, electro-optics assembly, polymer optics molding, glass optics molding, opto-mechanical assembly, nanomachining and thin films coating. Our facility also provides availability to expand the number of advanced manufacturing processes to handle increased volumes of existing and new customer orders.

     

    Syntec Optics focuses on four end markets of defense, medical, consumer, and communications all with several mission-critical applications with strong tailwinds.

     

    In 2023, Syntec Optics launched low weight night vision optics and further, announced hybrid light-weight magnifier and thermal clip on in the defense end market. Also, in 2023, Syntec Optics announced biomedical mirrors for sensing in the medical end market. Rounding out new product launches for 2023, in the communication end market, Syntec Optics launched microlens arrays and low earth satellite optics.

     

    12
     

     

    Key Factors Affecting Our Operating Results

     

    Our financial position and results of operations depend to a significant extent on the following factors:

     

    End Market Consumers

     

    The demand for our products ultimately depends on demand from customers in our current end markets. We generate sales through (1) Tier 1 suppliers and (2) through OEMs.

     

    An increasing proportion of our sales has been and is expected to continue to be derived from sales to defense. biomedical and industrial/consumer OEMs, driven by continued efforts to develop and expand sales to OEMs with whom we have longstanding relationships. Future OEM sales will be subject to risks and uncertainties, including the number of defense, biomedical and industrial/consumer products these OEMs manufacture and sell, which in turn may be driven by the expectations these OEMs have around end market demand.

     

    Demand from end markets is impacted by a number of factors, including travel restrictions (global pandemics or geo-political conflicts), fuel costs and energy demands (including an increasing trend towards the use of green energy), as well as overall macro-economic conditions. Sales of our optics and photonics enabled components and sub-components have also benefited from the increased global conflict, the United States dynamic relationships with other world powers that may have a conflicting view with western-style democracy, the movement towards reshoring of advanced manufacturing, biomedical components and sub-components needed to support physicians in their battle against global pandemics, and the increased global demand for high-fidelity data communications on all corners of the globe.

     

    Syntec Optics plans to further add bolt-on acquisitions for inorganic growth in the fragmented photonics industry by expanding our portfolio of our existing, U.S.-based, advanced manufacturing processes of making thin-film coated glass, crystal, or polymer components and their housings, which are ultimately assembled into high performance hybrid electro-optics sub-systems. By doing so, Syntec Optics plans to grow to the new end markets of communications and sensing. Syntec Optics entered the communications end market in 2023. Syntec Optics is currently engaged as a supplier for a U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) funded research and development project for the sensing end market. The communication end market is characterized by the use of optics and photonics for data transmittal and reception of information, including, for example, satellite communications and other associated applications. The sensing end-market is characterized by the use of optics and photonics to detect scattered light or light with an altered refractive index due to the presence of a medium within a wide range of potential applications, including, for example, disease detection and other associated applications.

     

    Supply

     

    We currently rely on strategically selected electronics, highly engineered polymers and aluminum manufacturers located in the United States to manufacture our highly specialized optic and photonics enabled components and sub-components, and we intend to continue to rely on these suppliers going forward. Our close working relationships with our Unites States based suppliers, reflected in our ability to (x) increase our purchase order volumes (qualifying us for related volume-based discounts) and (y) order and receive delivery of raw materials in anticipation of required demand, has helped us moderate increased supply-related costs associated with inflation and to avoid potential shipment delays. To mitigate against potential adverse production events, we opted to build our inventory of key raw materials. In connection with these stockpiling activities, we experienced an increase in prepaid inventory compared to prior periods as suppliers required upfront deposits in response to supply chain disruptions.

     

    As a result of the active steps we have taken to manage our inventory levels, we have not been subject to the shortages or price impacts that have been present for manufacturers of optic and photonic enabled components or sub-components.

     

    Product and Customer Mix

     

    Our sales consist of sales of highly specialized optic and photonic enabled components and sub-components. These products are sold to different customer types (e.g., OEMs and Tier 1 manufacturers) and at different prices and involve varying levels of costs. In any particular period, changes in the mix and volume of particular products sold and the prices of those products relative to other products will impact our average selling price and our cost of goods sold. The price of our products may also increase as a result of increases in the cost of components due to inflation, labor and raw materials. The Company generated 46% of revenues for the three months ended March 31, 2025 from three customers and 53% of revenues for the three months ended March 31, 2024 from three customers. These customers have a broad product purchase mix across various departments of Syntec Optics. Syntec Optics supplies several mission critical components and sub-components to these customers that are not tied to a single application, customer initiative, or purchase order. We expect sales to increase as we further advance our full-system design expertise and product offerings and customers increasingly demand more sophisticated systems, rather than drop-in replacements. In addition to the impacts attributable to the general sales mix across our products, our results of operations are impacted by the relative margins of products sold. As we continue to introduce new products at varying price points, our overall gross margin may vary from period to period as a result of changes in product and customer mix.

     

    Production Capacity

     

    All of our design, advanced manufacturing and assembly currently takes place at our nearly 90,000 square foot headquarters and manufacturing facility located in Rochester, New York. We currently operate optical, opto-mechanical and electro-optical assembly lines in addition to molding, nanomachining, testing and thin-film production lines. Consistent with our operating history, we plan to continue to automate additional aspects of our advanced manufacturing operations. Our existing facility has the capacity to add additional production lines and construct and operate pilot production lines for new components and sub-components, all designed to maximize the capacity of our manufacturing facility. Although our automation efforts are expected to reduce our costs of goods, we may not fully recognize the anticipated savings when planned and could experience additional costs or disruptions to our production activities.

     

    13
     

     

    Competition

     

    We compete with traditional glass optic manufacturers and electro-optic manufacturers, who primarily either import their products or components or manufacture products under a private label. As we continue to expand into new markets, develop new products and move towards production of our polymer based and glass-polymer based optic hybrids and photonics enabled components and sub-components, we will experience competition with a wider range of companies. These competitors may have greater resources than we do and may be able to devote greater resources to the development of their current and future technologies. Our competitors may be able to source materials and components at lower costs, which may require us to evaluate measures to reduce our own costs, lower the price of our products or increase sales volumes in order to maintain our expected levels of profitability.

     

    Research and Development

     

    Our research and development are primarily focused on the advanced manufacturing of polymer and glass-polymer based optic and photonics enabled components and sub-components. The next stage in our technical development is to construct our products to optimize performance, lower weight and increase longevity to meet and exceed industry standards for our target end markets. Ongoing testing and optimizing of more complicated systems and sub-systems for our existing end markets will assist us in increasing penetration in our current end markets and expanding into targeted end markets.

     

    Components of Results of Operations

     

    Net Sales

     

    Net sales are primarily generated from the sale of our optics and photonics enabled components and sub-components to OEMs.

     

    Cost of Goods Sold

     

    Cost of goods sold includes the cost of raw materials and other components of our optic and photonic enabled components and sub-components, labor, overhead, utilities, and depreciation and amortization.

     

    Gross Profit

     

    Gross profit, calculated as net sales less cost of goods sold, may vary between periods and is primarily affected by various factors including average selling prices, product costs, product mix, customer mix and production volumes.

     

    Operating Expenses

     

    General and Administrative

     

    General and administrative costs include personnel-related expenses attributable to our executive, finance, human resources, and information technology organizations, certain facility costs, and fees for professional services.

     

    Total Other Income (Expense)

     

    Other income (expense) consists primarily of interest expense and debt issuance costs.

     

    Results of Operations

     

    Comparisons for the Three Months Ended March 31, 2025 and 2024

     

    The following table sets forth our results of operations for the three months ended March 31, 2025 and 2024, respectively. This data should be read together with our financial statements and related notes included elsewhere in this Quarterly Report, and is qualified in its entirety by reference to such financial statements and related notes.

     

       Three Months ending 
       March 31, 2025   % Net Sales   March 31, 2024   % Net Sales 
    Net Sales  $7,069,042    100%  $6,255,908    100%
    Cost of Goods Sold   4,760,424    67%   5,548,465    89%
    Gross Profit   2,308,618    33%   707,443    11%
    General and Administrative Expenses   1,780,166    25%   2,114,543    34%
    Income (Loss) from Operations   528,452    7%   (1,407,100)   -22%
    Other Income (Expense)                    
    Interest Expense, Including Amortization of Debt Issuance Costs   (200,896)   -3%   (159,867)   -3%
    Other Income   5,697    0%   19,349    0%
    Total Other (Expense)   (195,199)   -3%   (140,518)   -2%
    Income (Loss) Before Provision (Benefit) for Income Taxes   333,253    5%   (1,547,618)   -25%
    Provision (Benefit) for Income Taxes   9,588    0%   (338,475)   -5%
    Net Income (Loss)  $323,665    5%  $(1,209,143)   -19%

      

    14
     

     

    Net Sales

     

    Net sales increased by $0.8 million, or 13.0%, to $7.1 million for the three months ended March 31, 2025, as compared to $6.3 million for the three months ended March 31 2024. This increase was primarily due to an increase of $1.1 million spread across the medical and defense end markets offset by a decrease of $0.2 million in the communications end market.

     

    Cost of Goods Sold

     

    Cost of revenue decreased by $0.7 million, or 14.2%, to $4.8 million for the three months ended March 31, 2025, as compared to $5.5 million for the three months ended March 31 2024. This decrease was primarily due to an efficiency driven decrease of $0.3 million in direct payroll, and an efficiency driven decrease of $0.6 million in direct material costs.

     

    Gross Profit

     

    Gross profit increased by $1.6 million, or 226%, to $2.3 million for the three months ended March 31, 2025, as compared to $0.7 million for the three months ended March 31 2024. This increase was due to improvements across all cost of goods sold areas.

     

    General and Administrative Expenses

     

    General and administrative expenses decreased by $0.3 million, or 16%, to $1.8 million for the three months ended March 31, 2025, as compared to $2.1 million for the three months ended March 31 2024. This decrease was primarily due to reductions in costs for advertising and outside consultants.

     

    Total Other Income (Loss)

     

    Other income (expense) increased by $0.05 million, or 38.9%, to ($0.20) million for the three months ended March 31, 2025, as compared to other income (expense) of ($0.14) million for the three months ended March 31 2024. This increase was primarily due to an increase in interest expense driven by higher rates.

     

    Income Tax Expense (Benefit)

     

    Income tax expense increased by $0.35 million, or 103%, to $0.01 million for the three months ended March 31, 2025, as compared to ($0.34) million for the three months ended March 31, 2024. This increase was primarily due to the increase in net income.

     

    Net Income (Loss)

     

    Net income (loss) improved by $1.5 million, to $0.3 million for the three months ended March 31, 2025, as compared to a loss of $1.2 million for the three months ended March 31, 2024. This improvement was primarily due to the reasons discussed above in Net Sales, Cost of Goods Sold, and General and Administrative Expenses.

     

    Critical Accounting Estimates

     

    Our condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States. The preparation of these condensed consolidated financial statements requires us to make judgments and estimates that affect the reported amounts of assets, liabilities, revenues and expenses, and the disclosure of contingent assets and liabilities in our financial statements. We base our estimates on historical experience, known trends and events and various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Our actual results may differ from these estimates under different assumptions or conditions. On a recurring basis, we evaluate our judgments and estimates in light of changes in circumstances, facts, and experience. The effects of material revisions in an estimate, if any, will be reflected in the consolidated financial statements prospectively from the date of the change in the estimate.

     

    We believe that the following accounting policies are those most critical to the judgments and estimates used in the preparation of our financial statements.

     

    Inventory Valuation

     

    We periodically review physical inventory for excess, obsolete, and potentially impaired items and reserves. Any such inventory is written down to net realizable value. The reserve estimate for excess and obsolete inventory is dependent on expected future use and requires management judgement.

     

    15
     

     

    Income Taxes

     

    We account for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences of temporary differences between the carrying amounts and tax bases of assets and liabilities using enacted rates. The effect of a change in tax rates on deferred taxes is recognized in income in the period that includes the enactment date.

     

    We recognize the financial statement effect of an uncertain income tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. Recognized income tax positions are measured at the largest amount that is greater than 50% likely to be realized. A valuation allowance is recorded to reduce deferred income tax assets to an amount, which in the opinion of management is more likely than not to be realized.

     

    Management judgment is required in determining our provision for income taxes, our deferred tax assets and liabilities, and any valuation allowance recorded against our deferred tax assets. We consider factors such as the cumulative income or loss in recent years; reversal of deferred tax liabilities; projected future taxable income exclusive of temporary differences; the character of the income tax asset, including income tax positions; tax planning strategies and the period over which we expect the deferred tax assets to be recovered in the determination of the valuation allowance. In the event that actual results differ from these estimates, or we adjust our estimates in the future, we may need to adjust our valuation allowance, which could materially impact our financial position and results of operations.

     

    Non-GAAP Financial Measures

     

    This Quarterly Report includes a non-generally accepted account principles within the United States (“U.S. GAAP”) measure that we use to supplement our results presented in accordance with U.S. GAAP. EBITDA is defined as earnings before interest and other income, tax and depreciation and amortization. Adjusted EBITDA is calculated as EBITDA adjusted for non-recurring items, and business combination expenses. Adjusted EBITDA is a performance measure that we believe is useful to investors and analysts because it illustrates the underlying financial and business trends relating to our core, recurring results of operations and enhances comparability between periods.

     

    Adjusted EBITDA is not a recognized measure under U.S. GAAP and is not intended to be a substitute for any U.S. GAAP financial measure and, as calculated, may not be comparable to other similarly titled measures of performance of other companies in other industries or within the same industry. Investors should exercise caution in comparing our non-GAAP measure to any similarly titled measure used by other companies. This non-GAAP measure excludes certain items required by U.S. GAAP and should not be considered as an alternative to information reported in accordance with U.S. GAAP.

     

    Adjusted EBITDA

     

    We define adjusted EBITDA, a non-GAAP financial measure, as net earnings (loss) before interest and other expenses, net, income tax expense, depreciation and amortization, as adjusted to exclude non-recurring items. We utilize adjusted EBITDA as an internal performance measure in the management of our operations because we believe the exclusion of these non-cash and non-recurring charges allow for a more relevant comparison of our results of operations to other companies in our industry and is in accordance with the Non-GAAP Financial Measures Compliance & Disclosure Interpretations (Reference Question 102.03).

     

    The Company has identified several non-recurring items included in our non-GAAP adjusted EBITDA financial measure. These items encompass management fees, professional & transaction fees, technology start-up costs, optical molding evaluation expenses, glass molding evaluation expenses, and executive transition expenses

     

    The table below presents our adjusted EBITDA, reconciled to net income for the three months ended March 31, 2025 and 2024.

     

    NON-GAAP RECONCILIATION OF EBITDA

    FOR THE THREE MONTHS ENDED MARCH 31, 2025 AND 2024

     

     

        2025    2024 
    Net (Loss) Income  $323,665   $(1,209,143)
    Depreciation & Amortization   710,804    695,826 
    Debt Issuance Costs   2,416    1,973 
    Interest Expenses   201,956    157,895 
    Taxes   9,588    (338,475)
    Non-Recurring Items        
    Executive Transition 

    113,944     
    One time Contract exit costs 

    4,675     
    Non-recurring property damage 

    21,261     
    Professional & Transaction Fees      25,265 
    Technology Start-up Costs     

    165,034 
    Optical Molding Evaluation Expenses     

    38,104 
    Glass Molding Evaluation Expenses     

    68,392 
    Adjusted EBITDA  $1,388,309   $(395,129)
    as percent of Revenue   20%   -6%

     

    16
     

     

    Liquidity and Capital Resources

     

    Liquidity describes the ability of a company to generate sufficient cash flows and operating profitability to meet the cash requirements of its business operations, including working capital needs, debt service, acquisitions, contractual obligations and other commitments. We assess liquidity in terms of our cash flows from operations and their sufficiency to fund our operating and investing activities. As of March 31, 2025, our principal sources of liquidity were cash totaling $0.5 million and a line of credit with $1.7 million available.

     

    Significant factors affecting the management of our ongoing cash requirements are the adequacy of available bank lines of credit and our ability to attract long-term capital with satisfactory terms. The sources of our liquidity are subject to all of the risks of our business and could be adversely affected by, among other factors, risks associated with events outside of our control, monetary policy changes in the U.S. and other countries and their impact on the global financial markets, supply chain disruptions and electronics and other material shortages, a decrease in demand for our products, our ability to integrate current and future acquisitions, deterioration in certain financial ratios, availability of borrowings under our revolving credit facility, and other market changes in general. See “Risks Relating to Syntec Optics’ Financial Position and Capital Requirements” included in Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024.

     

    Cash Flow — Three Months Ended March 31, 2025 and 2024

     

       Three Months ending March 31 
       2025   2024 
    Net Cash Provided (Used) by Operating Activities 

    $

    299,290  

    $

    (289,841)
    Net Cash Used in Investing Activities   (214,731)   

    (95,218

    )
    Net Cash (Used) Provided in Financing Activities  $(142,442)  $

    1,011,510

     

    Operating Activities

     

    Net cash provided by operating activities was $0.3 million for the three months ended March 31, 2025. During the same period in the prior year, operating activities used net cash of $0.3 million.

     

    Investing Activities

     

    Net cash used in investing activities was $0.2 million for the three months ended March 31, 2025, as compared to net cash used in investing activities of $0.1 million for the three months ended March 31, 2024. The net cash used in investing activities increased primarily due to an increase in payment for capital expenditures.

     

    Financing Activities

     

    Net cash used in financing activities was $0.1 million for the three months ended March 31, 2025, as compared to net cash provided in financing activities of $1.0 million for the three months ended March 31, 2024. The primary drivers for the year-over-year change was a reduction in borrowing of $1.1 million.

     

    ITEM 3. Quantitative and Qualitative Disclosures about Market Risk

     

    Our primary market risk exposure is interest rate sensitivity. During the three months ended March 31, 2025, there have been no material changes to the information included under Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk,” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024.

     

    17
     

     

    Item 4. Controls and Procedures

     

    Evaluation of Disclosure Controls and Procedures

     

    As required by Rule 13a-15 under the Exchange Act, we have carried out an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Report. This evaluation was carried out under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer.

     

    Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include controls and procedures designed to ensure that information required to be disclosed in our company’s reports filed under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the controls system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected. Based on the evaluation of our disclosure controls and procedures as of March 31 2025, our Chief Executive Officer and our Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were not effective due to the following identified material weaknesses:

     

    1. We lack documentation of formal internal control process and controls including lack of review of journal entries.
    2. We lack necessary corporate accounting resources to maintain adequate segregation of duties.
    3. We lack timely reconciliation controls in the areas of classification of revenue, accounts payable, accrued legal expenses, provision for income taxes, and inventory.
    4. We lack controls related to proper cut-off of costs of goods sold and general and administrative expenses.
    5. We lack control related to identification and disclosure of related party transactions.
    6. We lack control related to proper fair value methodology utilized for valuation of complex financial instrument in connection with contingent earnout arrangement.
    7. We lack the necessary information technology (“IT”) general controls infrastructure in the areas of user access and program change-management due to insufficient documentation and training, and inadequate IT risk assessment process. Additionally, we lack controls around the review of SOC-1 reports and lack of cyber security related controls.
    8. We lack control related to the evaluation and calculation of finance leases in accordance with Accounting Standards Codification 842-20-25-1a.
      9. We lack control related to identification of stock-based compensation agreements and related accounting for and disclosure of such agreements.

     

    Remediation Plans and Status

     

    As disclosed in the section titled “Evaluation of Internal Controls and Procedures,” we have identified certain control deficiencies. To address these issues, we have designed and are in the process of implementing the following remediation initiatives, which are aligned with the COSO framework:

     

    ●Enhance corporate governance through increased oversight by the Audit Committee, including additional reviews of internal control improvements and financial statements prior to publication (Control Environment; Monitoring Activities).
    ●Design and implement internal control flowcharts to strengthen segregation of duties (Control Activities; Risk Assessment).
    ●Increase staffing levels and competencies to enable appropriate separation of duties (Control Environment; Control Activities).
    ●Implement a formal checklist, review process, and controls over all journal entries and modifications to trial balances (Control Activities; Information & Communication).
    ●Hire additional experienced accounting and reporting professionals to prepare and approve consolidated financial statements and footnote disclosures in accordance with U.S. GAAP (Control Environment; Control Activities).
    ●Engage outside professional support to assist with SEC reporting requirements and special circumstances to ensure timely and accurate filings (Control Environment; Information & Communication).
    ●Establish a formal quarterly attestation process for managers and accounting staff to reinforce and monitor the use of control processes and workflows (Monitoring Activities; Information & Communication).
    ●Implement a formalized system for tracking control measures to reduce complexity and improve management’s review of control effectiveness (Monitoring Activities; Information & Communication).

     

    While the Company has initiated these remediation efforts, not all measures have been fully implemented as of the date of this filing. We will continue to enhance our internal control framework, employ additional procedures, and utilize appropriate tools and resources to ensure that our consolidated financial statements are presented fairly, in all material respects.

     

    The Company believes these remediation measures will significantly strengthen its internal control environment and provide the foundation to remediate the identified material weaknesses in future reporting periods.

     

    Management’s Report on Internal Control over Financial Reporting

     

    This Report does not include a report of management’s assessment regarding internal control over financial reporting or an attestation report of the Company’s registered public accounting firm due to a transition period established by rules of the SEC for newly public companies. Additionally, our auditors will not be required to formally opine on the effectiveness of our internal control over financial reporting pursuant to Section 404 until we are no longer an “emerging growth company” as defined in the JOBS Act.

     

    Changes in Internal Control over Financial Reporting

     

    Other than the material weaknesses and remediation efforts mentioned above, there were no changes in our internal controls over financial reporting that occurred during the quarter ended March 31, 2025 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

     

    18
     

     

    PART II - OTHER INFORMATION

     

    Item 1. Legal Proceedings

     

    We may be subject to legal proceedings, investigations and claims incidental to the conduct of our business from time to time. We are not currently a party to any material litigation or other legal proceedings brought against us. We are also not aware of any legal proceeding, investigation or claim, or other legal exposure that has a more than remote possibility of having a material adverse effect on our business, financial condition or results of operations.

     

    Item 1A. Risk Factors

     

    The Company’s risk factors are described in Part I, Item 1A, “Risk Factors”, of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024. The risks described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial position, or future results of operations. The risk factors should be read together with, the risk factors described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024.

     

    Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

     

    None

     

    Item 3. Defaults Upon Senior Securities

     

    None

     

    Item 4. Mine Safety Disclosures

     

    Not Applicable

     

    Item 5. Other Information

     

    None

     

    Item 6. Exhibits

     

    The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

     

    No. Description of Exhibit
    3.1* Certificate of Incorporation of the Registrant, dated October 31, 2023
    3.2* By laws of the Registrant, dated October 31, 2023
    31.1* Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
    31.2* Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
    32.1** Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
    32.2** Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

     

    101.INS Inline XBRL Instance Document
    101.SCH Inline XBRL Taxonomy Extension Schema Document
    101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document
    101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document
    101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document
    101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document
    104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

    * Filed herewith.
       
    ** Furnished.

     

    19
     

     

    SIGNATURES

     

    In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

    SYNTEC OPTICS HOLDINGS INC.
       
    Date: October 3, 2025 By: /s/ Al Kapoor
    Name: Al Kapoor
    Title: Chairman and Chief Executive Officer
    (Principal Executive Officer)
         
    Date: October 3, 2025 By: /s/ Dean Rudy
    Name: Dean Rudy
    Title: Chief Financial Officer
    (Principal Accounting Officer and Financial Officer)

     

    20

     

    Get the next $OPTX alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $OPTX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $OPTX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Syntec Optics Holdings, Inc. (Nasdaq: OPTX) Reports Full Year 2024 and First Half 2025 Financial Results

    ROCHESTER, NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. ("Syntec Optics" or the "Company") (NASDAQ:OPTX), a leading provider of mission-critical products to advanced technology defense, biomedical, and communications equipment & scientific instruments manufacturers, reported financial and operational results for the full year 2024 and first half 2025. Full Year 2024 Financial Highlights Sales from products increase by $1.9 million year-over-yearAdjusted EBITDA of $2.2 million was positive but down $3.1 million from the 2023 adjusted EBITDA of $5.3 millionCash, including available lines of credit, was nearly $5.1 million First Half 2025 Financial Highlights N

    10/6/25 6:34:23 AM ET
    $OPTX
    Electronic Components
    Technology

    Pitney Bowes Announces Election of Brent Rosenthal as Independent Chair of its Board of Directors

    Thanks Milena Alberti-Perez for Her Leadership as Independent Chair and Numerous Contributions to the Company's Successful Turnaround Pitney Bowes Inc. (NYSE:PBI) ("Pitney Bowes" or the "Company"), a technology-driven products and services company that provides SaaS shipping solutions, mailing innovation, and financial services to clients around the world, today announced that its Board of Directors (the "Board") has elected Brent Rosenthal as its new independent Chair, effective immediately. Mr. Rosenthal succeeds Milena Alberti-Perez, who served with distinction as independent Chair and, prior to that, as a highly engaged independent director during the Company's successful multi-year t

    10/3/25 8:00:00 AM ET
    $OPTX
    $PBI
    $SCHL
    Electronic Components
    Technology
    Office Equipment/Supplies/Services
    Miscellaneous

    Syntec Optics (Nasdaq: OPTX) to Host Conference Call to Discuss Financial Results and Business Update

    ROCHESTER, NEW YORK, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Syntec Optics, a leading provider of mission-critical optics to scientific and technical instruments and equipment OEMs in diverse defense, biomedical, communications, and consumer end-markets, today announced it will host a conference call to discuss its financial results and provide a business update on Tuesday, September 16, 2025, at 5:00 p.m. Eastern Time (ET). Conference Call Details: Date: Tuesday, September 16, 2025 Time: 5:00 p.m. ET Register in Advance (Required): https://us06web.zoom.us/meeting/register/q__txHvFRXKFwtPinLTRTg (After registering, you will receive a confirmation email containing information about joining

    9/12/25 4:15:00 PM ET
    $OPTX
    Electronic Components
    Technology

    $OPTX
    SEC Filings

    View All

    Syntec Optics Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - SYNTEC OPTICS HOLDINGS, INC. (0001866816) (Filer)

    10/6/25 6:58:59 AM ET
    $OPTX
    Electronic Components
    Technology

    SEC Form 10-K filed by Syntec Optics Holdings Inc.

    10-K - SYNTEC OPTICS HOLDINGS, INC. (0001866816) (Filer)

    10/3/25 8:09:12 PM ET
    $OPTX
    Electronic Components
    Technology

    SEC Form 10-Q filed by Syntec Optics Holdings Inc.

    10-Q - SYNTEC OPTICS HOLDINGS, INC. (0001866816) (Filer)

    10/3/25 8:20:39 PM ET
    $OPTX
    Electronic Components
    Technology

    $OPTX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Rosenthal Brent D

    4 - SYNTEC OPTICS HOLDINGS, INC. (0001866816) (Issuer)

    10/8/25 2:57:37 PM ET
    $OPTX
    Electronic Components
    Technology

    SEC Form 4 filed by Director Manzone Albert

    4 - SYNTEC OPTICS HOLDINGS, INC. (0001866816) (Issuer)

    10/8/25 2:54:36 PM ET
    $OPTX
    Electronic Components
    Technology

    SEC Form 4 filed by Director Bishop Walter A.

    4 - SYNTEC OPTICS HOLDINGS, INC. (0001866816) (Issuer)

    10/8/25 7:55:21 AM ET
    $OPTX
    Electronic Components
    Technology

    $OPTX
    Financials

    Live finance-specific insights

    View All

    Syntec Optics (Nasdaq: OPTX) to Host Conference Call to Discuss Financial Results and Business Update

    ROCHESTER, NEW YORK, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Syntec Optics, a leading provider of mission-critical optics to scientific and technical instruments and equipment OEMs in diverse defense, biomedical, communications, and consumer end-markets, today announced it will host a conference call to discuss its financial results and provide a business update on Tuesday, September 16, 2025, at 5:00 p.m. Eastern Time (ET). Conference Call Details: Date: Tuesday, September 16, 2025 Time: 5:00 p.m. ET Register in Advance (Required): https://us06web.zoom.us/meeting/register/q__txHvFRXKFwtPinLTRTg (After registering, you will receive a confirmation email containing information about joining

    9/12/25 4:15:00 PM ET
    $OPTX
    Electronic Components
    Technology

    Syntec Optics (Nasdaq: OPTX) to Host Conference Call to Discuss Financial Results and Business Update

    ROCHESTER, NEW YORK, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Syntec Optics (NASDAQ:OPTX), a leading provider of mission-critical products to advanced technology defense, biomedical, and communications equipment manufacturers, today announced it will host a conference call on Monday, November 18, 2024, at 5:00 p.m. Eastern Time (ET) to discuss its financial results and provide a business update. With nearly 11% of the global GDP light-enabled, Syntec Optics Chairman and CEO Al Kapoor delivered a keynote speech on the Future of Photonics  at the Global Photonics Forum in Malaga, Spain, on October 1-2, 2024. At this event organized by Optica, a Society that advances optics and photonics worldwide,

    11/15/24 11:37:46 AM ET
    $OPTX
    Electronic Components
    Technology

    Syntec Optics (Nasdaq: OPTX) to Host Conference Call to Discuss Financial Results and Business Update

    ROCHESTER, NEW YORK, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Syntec Optics, a leading provider of mission-critical optics for scientific and technical instruments and equipment OEMs in diverse defense, biomedical, communications, and consumer end-markets, today announced it will host a conference call to discuss its financial results and provide a business update on Thursday, August 15, 2024, at 5:00 p.m. Eastern Time (ET). Conference Call Details: Date: Thursday, August 15, 2024 Time: 5:00 p.m. ET Dial-In Number: +16469313860,,84095219819#,,,,*311664# (Please dial in prior to the call) Webcast: A recording of the conference call will be available on the Events & Presentations p

    8/13/24 4:30:00 PM ET
    $OPTX
    Electronic Components
    Technology

    $OPTX
    Leadership Updates

    Live Leadership Updates

    View All

    Pitney Bowes Strengthens Board of Directors with the Appointment of Brent Rosenthal

    Pitney Bowes Inc. (NYSE:PBI) ("Pitney Bowes" or the "Company"), a technology-enabled services company that provides SaaS shipping solutions, mailing innovation and financial services to clients around the world, today announced that it has appointed Brent Rosenthal to its Board of Directors (the "Board"), effective immediately. Mr. Rosenthal has extensive Board experience as well as over thirty years of investment expertise. Mr. Rosenthal's experience as an investor and operator in the technology industry, as well as his understanding of public company governance, supports the Company's strategic focus on digital transformation, disciplined capital allocation and enhanced Board and leader

    6/17/25 4:05:00 PM ET
    $OPTX
    $PBI
    Electronic Components
    Technology
    Office Equipment/Supplies/Services
    Miscellaneous

    Webull Appoints Walter Bishop to Board of Directors

    Mr. Bishop to serve as Independent Director and member of the Audit, Compensation and Nominating and Corporate Governance Committees ST. PETERSBURG, Fla., June 9, 2025 /PRNewswire/ --  Webull Corporation (NASDAQ:BULL) ("Webull" or the "Company"), the owner of the Webull online investment platform, today announced the appointment of Walter Bishop as independent director to its Board of Directors, effective June 8, 2025. Mr. Bishop will serve as a member of the Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee. Mr. Bishop brings extensive

    6/9/25 8:45:00 AM ET
    $BULL
    $DB
    $INDI
    Investment Bankers/Brokers/Service
    Finance
    Major Banks
    Semiconductors

    Syntec Optics (Nasdaq: OPTX) Adds Tom Lopa to the Team as Director of Opto-Mechanicals

    ROCHESTER, NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (NASDAQ:OPTX), a leading provider of technology products to defense, biomedical, communications, and consumer industry leaders, today announced that Tom Lopa has joined the company as Director of Opto-Mechanicals. Mr. Lopa brings extensive experience in manufacturing operations, strategic leadership, and manufacturing process optimization to Syntec Optics. In his new role, Mr. Lopa will lead and increase production for aiming, satellite, biomedical, and night vision opto-mechanical products. These Syntec products enable light for diverse end markets like defense, communication, biomedical, and consumer b

    4/29/25 8:29:15 AM ET
    $OPTX
    Electronic Components
    Technology